CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.710
0.00 (0.00%)
Apr 29, 2026, 9:30 AM EDT - Market open
CervoMed Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -26.97 | -16.29 | -2.17 | -5.8 | -4.14 |
| Loss (Gain) From Sale of Investments | -0.85 | -1.21 | - | - | - |
| Stock-Based Compensation | 1.45 | 1.41 | 0.41 | 0.46 | 0.96 |
| Other Operating Activities | - | - | -5.42 | 2.39 | -0.9 |
| Change in Accounts Payable | -0.07 | 0.85 | 0.57 | 0.08 | -0.15 |
| Change in Other Net Operating Assets | 2.99 | -1.29 | -0.83 | 0.3 | 0.1 |
| Operating Cash Flow | -23.45 | -16.53 | -7.45 | -2.57 | -4.13 |
| Investment in Securities | 18.1 | -28.66 | - | - | - |
| Investing Cash Flow | 18.1 | -28.66 | - | - | - |
| Long-Term Debt Issued | - | - | - | - | 6 |
| Net Debt Issued (Repaid) | - | - | - | - | 6 |
| Issuance of Common Stock | 4.59 | 46.4 | 0.81 | - | - |
| Other Financing Activities | - | - | 10.34 | - | - |
| Financing Cash Flow | 4.59 | 46.4 | 11.15 | - | 6 |
| Net Cash Flow | -0.76 | 1.21 | 3.7 | -2.57 | 1.87 |
| Levered Free Cash Flow | -13.31 | -10.69 | -4.73 | -1.33 | - |
| Unlevered Free Cash Flow | -13.31 | -10.69 | -4.73 | -1.33 | - |
| Change in Working Capital | 2.92 | -0.44 | -0.26 | 0.38 | -0.06 |
Source: S&P Capital IQ. Standard template.
Financial Sources.